Helicobacter pylori nanoparticles as a potential treatment of conventional multiple sclerosis

Med Hypotheses. 2008;70(6):1223. doi: 10.1016/j.mehy.2007.12.008. Epub 2008 Jan 31.

Authors

Mohammad Zakaria Pezeshki, Sina Zarrintan, Mohammad Hossein Zarrintan

PMID: 18242004
DOI: 10.1016/j.mehy.2007.12.008

No abstract available

Publication types

Letter

MeSH terms

Drug Carriers / therapeutic use
Helicobacter Infections / complications*
Helicobacter Infections / immunology
Helicobacter pylori / immunology*
Humans
Models, Immunological*
Multiple Sclerosis / therapy*
Nanoparticles / therapeutic use*

Substances

Drug Carriers